Xencor To Replace HFF In The S&P SmallCap 600, Shares Rise

Xencor Inc XNCR shares are trading higher after it was announced the company will replace HFF Inc HF in the S&P SmallCap 600 on July 2.

Xencor is a pharmaceutical manufacturer with an emphasis on addressing severe diseases.

HFF provides capital markets and brokerage services to owners of commercial real estate. In March, Jones Lang LaSalle Inc. JLL announced it's acquiring HFF in a cash and stock transaction with an equity value of approximately $2 billion.

Xencor shares traded higher by 13% to $38.42 at time of publication Tuesday. The stock has a 52-week range between $48.38 and $27.75.

Related Links:

Genfit Partners With Terns Pharma To Develop, Commercialize Elafibranor In China

7 Stocks To Watch For June 25, 2019